WSL
KNTE

Western Standard LLC’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Western Standard LLC’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-102,780
Closed -$1.3M – 39
2022
Q2 		$1.3M Buy
+102,780
New +$1.3M 0.98% 28